Journals / Klinik Psikiyatri Dergisi / 2017 / Cilt: 20 - Sayı: 4

Paliperidone Metabolic Effects in Children and Adolescents: A Case Report

Çocuk/arda ve Ergen/erde Paliperidonun Metabo/ik Etki/eri: Bir Olgu Sunumu

Pages
86–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, paliperidone should be used carefully based on the side effects for patients under 18 yearsof age.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The use of atypical antipsychotics in children and adolescents has increased in recent years.
📊
Key Findings & Data:A 16-year-old malepatient reported that he had used paliperidone for 3years and had gained weight during this period.
💡
Conclusion & Impact:Thus, paliperidone should be used carefully based on the side effects for patients under 18 yearsof age.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The use of atypical antipsychotics in children and adolescents has increased in recent years. A 16-year-old malepatient reported that he had used paliperidone for 3years and had gained weight during this period. Variouslaboratory tests were performed when the patient started treatment in our clinic. It is evident from the testresult that 3-year use of paliperidone dramaticallyincreased fasting blood sugar, total cholesterol, low-density lipoprotein, triglycerides and prolactin levels in thepatient. The metabolic parameters of the patientdecreased into the normal range once the medicationwas stopped. Thus, paliperidone should be used carefully based on the side effects for patients under 18 yearsof age.

Özet

Son yıllarda atipik antipsikotiklerin çocuklar ve ergenlerde kullanımı artmıştır. 16 yaşındaki erkek hasta, paliperidonu yıl kullandığını ve bu dönemde kilo aldığını bildirmiştir. Kliniğimizde hastaya tedavi başlanmasıyla çeşitli laboratuvar testleri yapıldı. Test sonucuna göre paliperidonun yıllık kullanımının hastada açlık kan şekeri, total kolesterol, düşük yoğunluklu lipoprotein, trigliserid ve prolaktin düzeylerini önemli ölçüde artırdığı açıktır. İlaç kesildikten sonra hastanın metabolik parametreleri normal aralığa düştü. Bu nedenle, paliperidon, 18 yaşın altındaki hastalar için yan etkilere dayalı olarak dikkatle kullanılmalıdır.

🔖

Cite This Article

KEFAL, M. İ., KANDEMİR, H., SAPMAZ, Ş. Y., OZTURK, M., ÖZKAN, Y., ÖZKAN, Ö. G. (2017). Paliperidone Metabolic Effects in Children and Adolescents: A Case Report. Klinik Psikiyatri Dergisi, Cilt: 20 - Sayı: 4, 86–87. https://ajindex.com/articles/199413

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Almandil NB, Wong IC. Review on the current use of antipsy- chotic drugs in children and adolescents. Archives of Disease in Childhood-Education & Practice Edition, 2011; 96(5):192-196.
  2. Clarke WP, Chavera TA, Silva M, Sullivan LC, Berg KA. Signalling profile differences: paliperidone versus risperidone. British Journal of Pharmacology, 2013; 170(3):532-545. Fàbrega M, Sugranyes G, Baeza I. Two cases of long-acting paliperidone in adolescence. Therapeutic Advances in Psychopharmacology, 2015; 5(5):304-306.
  3. Sliwa JK, Fu DJ, Bossie CA, Turkoz I, Alphs L. Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate. BMC Psychiatry, 2014; 14(1):52.